In Dickson 2024 et al., on VATS for feline chylothorax, what was the study's overall conclusion about clinical outcomes?
A. It significantly reduced recurrence
B. It improved short-term outcomes
C. It was more effective than open surgery
D. It was technically feasible but did not improve outcomes
E. It eliminated the need for pleural drainage
Answer: It was technically feasible but did not improve outcomes
Explanation: VATS was feasible in cats, but mortality remained high and outcomes were not superior to open surgery.
In Dickson 2024 et al., on VATS for feline chylothorax, what percentage of cats required conversion to open surgery?
A. 0%
B. 7%
C. 13%
D. 20%
E. 27%
Answer: 20%
Explanation: Conversion was required in 3 of 15 cases (20%) due to bleeding or poor visualization.
In Dickson 2024 et al., on VATS for feline chylothorax, what was the most common postoperative complication?
A. Pneumothorax
B. Hemothorax
C. Seroma
D. Persistent pleural effusion
E. Arrhythmia
Answer: Persistent pleural effusion
Explanation: 5 of 15 cats developed persistent pleural effusion, the most frequent complication.
In Dickson 2024 et al., on VATS for feline chylothorax, which agents were used to visualize the thoracic duct?
A. Barium and iodine
B. Methylene blue and ICG
C. Furosemide and saline
D. Methylene blue and mannitol
E. ICG and fluorescein
Answer: Methylene blue and ICG
Explanation: Methylene blue (11 cats) and ICG (2 cats) were used for duct visualization.
In Dickson 2024 et al., on VATS for feline chylothorax, what was the survival rate to hospital discharge?
A. 27%
B. 40%
C. 60%
D. 73%
E. 100%
Answer: 73%
Explanation: 11 of 15 cats survived to hospital discharge, equating to a 73% discharge rate.